Tech Company Financing Transactions
Oraya Therapeutics Funding Round
Oraya Therapeutics, based in Newark, secured $2 million in funding from Morgenthaler Ventures and OVP Venture Partners.
Transaction Overview
Company Name
Announced On
12/31/2006
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series C
Investors
Morgenthaler Ventures (Gregory Blonder)
OVP Venture Partners (Gerard H. Langeler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8000 Jarvis Ave. 200
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
Founded in 2006, Oraya's first commercial application, the IRay system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Taylor
Chief Financial Officer
Ed Battle
VP - Bus. Development
Alan Czeszynski
VP - Regulatory Affairs
Astrid Berthe
Browse more venture capital transactions:
Prev: 12/31/2006: Channel Intelligence venture capital transaction
Next: 12/31/2006: ReGen Biologics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs